The group consists of 5 scientists, 3 postdocs, 5 PhD students, 6 research engineers and one MD-PhD student.
We seek to reach a more fundamental understanding of the biological dynamics of breast cancer through high-throughput molecular analyses of DNA, mRNA, miRNA and protein. We
perform "state of the art" analyses of patient material, both on bulk tumors, single cells and liquid biopsies, at various stages of the disease, from consecutive series (OsloVal, Oslo0, Oslo1 and Oslo2) and from clinic trials with sampling before, during, and after therapy (the NeoAva and the IBCT-study).
Professor Anne-Lise Børresen-Dale, Email: firstname.lastname@example.org
Department of Cancer Genetics, Institute for Cancer Research
The Norwegian Radium Hospital, N-0310 Oslo,Norway
Phone: +47 2278 1373, Fax: +47 2278 1395, Switchboard: +47 2293 4000
Apr 26, 2017
Apr 19, 2017
Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response
Breast Cancer (Dove Med Press), 9, 185-198
Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome
Breast Cancer Res, 19 (1), 44
Somatic mutations reveal asymmetric cellular dynamics in the early human embryo
Nature, 543 (7647), 714-718